Jordan Hyde
Dermatology · Philadelphia, PANPI 1992367056
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Johnson & Johnson at 28.2% of the total. Reporting peaked in 2024 at $2,664 and has fallen 65.1% since, to $930 in 2025.
Across 114 payments — averaging $59.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- Janssen Scientific Affairs, LLC$843
- AbbVie$822
- Regeneron Healthcare Solutions, Inc.$432
- UCB, Inc.$385
- Sanofi$361
- plus $2K from 11 others
What the payments were for
- Food & beverage$6,40595%
- Education$3645%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 59 | $1,910 |
| Janssen Scientific Affairs, LLC | 7 | $843 |
| AbbVie | 15 | $822 |
| Regeneron Healthcare Solutions, Inc. | 5 | $432 |
| UCB, Inc. | 4 | $385 |
| Sanofi | 4 | $361 |
| Arcutis Biotherapeutics, Inc. | 2 | $300 |
| Novartis | 3 | $296 |
| LEO Pharma Inc. | 3 | $273 |
| Sun Pharmaceutical Industries Inc. | 2 | $235 |
| Lilly USA, LLC | 2 | $215 |
| Galderma Laboratories, L.p. | 2 | $172 |
| Dermavant Sciences, Inc. | 1 | $135 |
| E.r. Squibb & Sons, L.L.C. | 1 | $133 |
| Boehringer Ingelheim | 1 | $125 |
| Cipher Pharmaceuticals US LLC | 1 | $90 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $42 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,768 in reported general payments places this provider in the 75th percentile of 626 dermatology providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 142 | $515,502 |
| Humira(Cf) PenAdalimumab | 31 | $206,731 |
| OtezlaApremilast | 24 | $113,928 |
| XolairOmalizumab | 23 | $61,821 |
| Clobetasol Propionate | 82 | $7,366 |
| Triamcinolone Acetonide | 47 | $828 |
| Clindamycin Phosphate | 17 | $706 |
| Ketoconazole | 52 | $642 |
| Permethrin | 11 | $493 |
| Hydrocortisone | 31 | $276 |
| Fluconazole | 12 | $171 |
| Doxycycline Hyclate | 11 | $124 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Philadelphia
- Stephen HessPhiladelphia$1.7M
- Joel GelfandPhiladelphia$649K
- Victoria WerthPhiladelphia$547K
- Nicholas MollanazarPhiladelphia$369K
- Harold FarberPhiladelphia$284K
- Jules LipoffPhiladelphia$259K
- Susan TaylorPhiladelphia$207K
- Joy WanPhiladelphia$176K
- Harold MilsteinPhiladelphia$120K
- David MargolisPhiladelphia$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.